Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 44Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Leukemia 19Leukemia, Myelomonocytic, Acute 11Leukemia, Monocytic, Acute 10Leukemia, Erythroblastic, Acute 9Congenital Abnormalities 8Leukemia, Megakaryoblastic, Acute 7Burkitt Lymphoma 6Myelodysplastic Syndromes 4Leukemia, Eosinophilic, Acute 4Myeloproliferative Disorders 3Lymphoma 3Leukemia, Biphenotypic, Acute 3Leukemia, Basophilic, Acute 3Recurrence 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Hematologic Neoplasms 2Thrombocytopenia 1Thrombocythemia, Essential 1Sarcoma, Myeloid 1Primary Myelofibrosis 1Polycythemia Vera 1Lymphoproliferative Disorders 1Lymphoma, Non-Hodgkin 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Immunoproliferative Disorders 1

Interventions

fluciclovine F-18 2Positron-Emission Tomography 2Injections 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2pembrolizumab 1ioflupane 1idelalisib 1aflibercept 1Water 1Vertical Dimension 1Methylene Blue 1Mammography 1Drug Delivery Systems 1Diagnosis, Computer-Assisted 1Daunorubicin 1Cytarabine 1Control Groups 1CPX-351 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Disease × Daunorubicin × Clear all
NCT00788892 2018-01-12

Trial of CPX-351 in Newly Diagnosed Elderly AML Patients

Jazz Pharmaceuticals

Phase 2 Completed
126 enrolled 12 charts
Other hematologic neoplasm

Disease, Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡